ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

The March: Research Task Force Calls For $10 Billion NCI Budget In 5 Years

October 2, 1998

NABCO to close June 30.

January 30, 2004

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995